Healthcare is looking toppy

Healthcare infrastructure has shown great investment potential in the past. But as David C Stevenson explains, the sector is starting to look overvalued.

There is one infrastructure sector I'm no longer so keen on the specialist healthcare sector. I've been bullish in the past, but it is starting to look ridiculously overvalued. Three of the main closed-end funds in the sector (Assura, MedicX and Primary Healthcare) are now worth a combined £3bn. That's a lot of money for a sector that didn't even exist a few years ago.

The business itself investing in medical properties still looks good. Ongoing demand for medical services and a squeeze on government spending means there are probably plenty of opportunities for it to grow further (the same goes for the social care and elderly housing sector).

Unfortunately, share prices are well ahead of the facts. Each of the three funds mentioned above now trades at a premium of around 20%. In other words, investors are paying £1.20 for every £1 of assets in the underlying portfolio. That compares very unfavourably to the already significant 10% premium the typical mainstream infrastructure fund trades at. While most of the rest of the stockmarket has dived by 5%-10% over the last year or so, these healthcare funds are up an average 9%.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

That's great if you bought them when I first tipped them, but they've come far enough these price levels are unsustainable. If you've made money, I strongly suggest taking some profits now. Don't get me wrong I'm not saying dump the lot, just scale back your investment. If you feel adventurous, you might even want to switch some profits into the one fund that doesn't look quite so overpriced.

Target Healthcare (LSE: THRL) invests in well-run, purpose-built care homes. It is now starting to appear on the radar of many wealth managers. It currently yields around 5.5% and trades at a discount of around 5% (partly because it's at an earlier stage of development than its peers in the sector).

This is by no means a risk-free business model there are widespread rumours of distress within the managed care-home market, with talk of bankruptcies among big players who have been hit by rising wages and falling local authority budgets. But while there might be more volatility in the sector, I think Target should continue to prosper and who knows, maybe it will end up trading at an extortionate premium over time too.

David C. Stevenson
Contributor

David Stevenson has been writing the Financial Times Adventurous Investor column for nearly 15 years and is also a regular columnist for Citywire. He writes his own widely read Adventurous Investor SubStack newsletter at davidstevenson.substack.com

David has also had a successful career as a media entrepreneur setting up the big European fintech news and event outfit www.altfi.com as well as www.etfstream.com in the asset management space. 

Before that, he was a founding partner in the Rocket Science Group, a successful corporate comms business. 

David has also written a number of books on investing, funds, ETFs, and stock picking and is currently a non-executive director on a number of stockmarket-listed funds including Gresham House Energy Storage and the Aurora Investment Trust. 

In what remains of his spare time he is a presiding justice on the Southampton magistrates bench.